11
|
Kort S, Willemse P, Habraken J, Haes H, Richel D, Willems D. The (un)importance of quality of life outcomes in palliative chemotherapy: A review of RCT’s in advanced colorectal cancer. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.8200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- S. Kort
- Acad Medcl Ctr, Amsterdam, The Netherlands; Acad Hosp Groningen, Groningen, The Netherlands
| | - P. Willemse
- Acad Medcl Ctr, Amsterdam, The Netherlands; Acad Hosp Groningen, Groningen, The Netherlands
| | - J. Habraken
- Acad Medcl Ctr, Amsterdam, The Netherlands; Acad Hosp Groningen, Groningen, The Netherlands
| | - H. Haes
- Acad Medcl Ctr, Amsterdam, The Netherlands; Acad Hosp Groningen, Groningen, The Netherlands
| | - D. Richel
- Acad Medcl Ctr, Amsterdam, The Netherlands; Acad Hosp Groningen, Groningen, The Netherlands
| | - D. Willems
- Acad Medcl Ctr, Amsterdam, The Netherlands; Acad Hosp Groningen, Groningen, The Netherlands
| |
Collapse
|
12
|
Wülfing C, Machiels JP, Richel D, Grimm MO, Treiber U, de Groot M, Beuzeboc P, Farrell J, Stone NL, Leopold L, El-Hariry I. A single arm, multicenter, open label, phase II study of lapatinib as 2L treatment of pts with locally advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.4594] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- C. Wülfing
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| | - J.-P. Machiels
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| | - D. Richel
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| | - M.-O. Grimm
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| | - U. Treiber
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| | - M. de Groot
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| | - P. Beuzeboc
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| | - J. Farrell
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| | - N. L. Stone
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| | - L. Leopold
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| | - I. El-Hariry
- Universitätsklinikum Münster, Münster, Germany; Clin Univ, St. Luc, Belgium; Acad Medisch Cedntrum, Amsterdam, The Netherlands; Heinrich-Heine-Universität, Duesseldorf, Germany; Klin Rechts der Isar - Medizinische Klin III, Muenchen, Germany; Medisch Spectrum Twente, Enschede, The Netherlands; Inst Curie, Paris, France; GlaxoSmithKline, London, United Kingdom; GlaxoSmithKline, Collegeville, PA
| |
Collapse
|
13
|
Klerk CPW, Smorenburg S, Otten HM, Richel D, Van Tienhoven G, Lensing A, Büller H, Prandoni P, Bos M, Prins M. Low-molecular-weight heparin and the survival of patients with advanced malignancy. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.8018] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- C. P. W. Klerk
- Academic Medical Center, Amsterdam, Netherlands; University Hospital of Padua, Padua, Italy; Reinier de Graaf Hospital, Delft, Netherlands; Academic Hospital Maastricht, Maastricht, Netherlands
| | - S. Smorenburg
- Academic Medical Center, Amsterdam, Netherlands; University Hospital of Padua, Padua, Italy; Reinier de Graaf Hospital, Delft, Netherlands; Academic Hospital Maastricht, Maastricht, Netherlands
| | - H.-M. Otten
- Academic Medical Center, Amsterdam, Netherlands; University Hospital of Padua, Padua, Italy; Reinier de Graaf Hospital, Delft, Netherlands; Academic Hospital Maastricht, Maastricht, Netherlands
| | - D. Richel
- Academic Medical Center, Amsterdam, Netherlands; University Hospital of Padua, Padua, Italy; Reinier de Graaf Hospital, Delft, Netherlands; Academic Hospital Maastricht, Maastricht, Netherlands
| | - G. Van Tienhoven
- Academic Medical Center, Amsterdam, Netherlands; University Hospital of Padua, Padua, Italy; Reinier de Graaf Hospital, Delft, Netherlands; Academic Hospital Maastricht, Maastricht, Netherlands
| | - A. Lensing
- Academic Medical Center, Amsterdam, Netherlands; University Hospital of Padua, Padua, Italy; Reinier de Graaf Hospital, Delft, Netherlands; Academic Hospital Maastricht, Maastricht, Netherlands
| | - H. Büller
- Academic Medical Center, Amsterdam, Netherlands; University Hospital of Padua, Padua, Italy; Reinier de Graaf Hospital, Delft, Netherlands; Academic Hospital Maastricht, Maastricht, Netherlands
| | - P. Prandoni
- Academic Medical Center, Amsterdam, Netherlands; University Hospital of Padua, Padua, Italy; Reinier de Graaf Hospital, Delft, Netherlands; Academic Hospital Maastricht, Maastricht, Netherlands
| | - M. Bos
- Academic Medical Center, Amsterdam, Netherlands; University Hospital of Padua, Padua, Italy; Reinier de Graaf Hospital, Delft, Netherlands; Academic Hospital Maastricht, Maastricht, Netherlands
| | - M. Prins
- Academic Medical Center, Amsterdam, Netherlands; University Hospital of Padua, Padua, Italy; Reinier de Graaf Hospital, Delft, Netherlands; Academic Hospital Maastricht, Maastricht, Netherlands
| |
Collapse
|